SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-105131
Filing Date
2021-04-02
Accepted
2021-04-02 15:54:21
Documents
5
Effectiveness Date
2021-04-02

Document Format Files

Seq Description Document Type Size
1 S-8 d269015ds8.htm S-8 76505
2 EX-5.1 d269015dex51.htm EX-5.1 6761
3 EX-23.1 d269015dex231.htm EX-23.1 1605
4 EX-23.2 d269015dex232.htm EX-23.2 1622
5 GRAPHIC g269015dsp01.jpg GRAPHIC 5692
  Complete submission text file 0001193125-21-105131.txt   95696
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255002 | Film No.: 21801931
SIC: 2834 Pharmaceutical Preparations